The Application Notebook
Short analyses time and high resolution are in great demand from R&D and QC departments within the pharmaceutical industry. Sub-two micron ODS reversed phase columns have recently been introduced to meet these requirements, but these columns require an ultra-high pressure HPLC system to achieve optimum performance. TSK-GEL ODS-140HTP, 2.3mm columns from Tosoh Bioscience have been developed to offer a combination of short analyses time and high resolution separations that can be run at modest pressures, making these columns compatible with conventional HPLC instrumentation. The polylayer bonding chemistry of these columns results in highly efficient and physically stable columns when operated at high linear velocities. In addition, TSK-GEL ODS-140HTP, 2.3mm columns can be efficiently operated at pressures not exceeding 9000psi in UPLC® and other ultra-high pressure HPLC systems, as well as in traditional HPLC systems.
Short analyses time and high resolution are in great demand from R&D and QC departments within the pharmaceutical industry. Sub-two micron ODS reversed phase columns have recently been introduced to meet these requirements, but these columns require an ultra-high pressure HPLC system to achieve optimum performance. TSK-GEL ODS-140HTP, 2.3μm columns from Tosoh Bioscience have been developed to offer a combination of short analyses time and high resolution separations that can be run at modest pressures, making these columns compatible with conventional HPLC instrumentation. The polylayer bonding chemistry of these columns results in highly efficient and physically stable columns when operated at high linear velocities. In addition, TSK-GEL ODS-140HTP, 2.3μm columns can be efficiently operated at pressures not exceeding 9000psi in UPLC® and other ultra-high pressure HPLC systems, as well as in traditional HPLC systems.
TSK-GEL ODS-140HTP, 2.3μm columns operate at lower pressure than competitive sub-2μm columns. This is illustrated in Figure 1. The pressure drop of a 5cm TSKgel ODS-140HTP, 2.3μm column at 25cm/min is more than 50% lower than that for smaller particle size competitive columns. Not surprisingly, the pressure drop over a 10cm TSKgel ODS-140HTP, 2.3μm column was still lower than any of the competitive 5cm columns.
Figure 1
To demonstrate the physical stability of the TSK-GEL ODS-140HTP, 2.3μm columns, they were subjected to more than 1000 multi-step gradient cycles at high flow rate. Figure 2 shows that the number of theoretical plates remained basically unchanged for a TSKgel ODS-140HTP column during 1110 gradient cycles consisting of five min step gradients from 10% to 50% and from 50% to 100% methanol at 0.6mL/min. During each cycle, pressure fluctuated between 30 and 60MPa as a result of changes in mobile phase viscosity. Figure 3 shows injections of test solutes after the first step gradient cycle and after 1110 cycles. The results clearly demonstrate the durability of the TSK-GEL ODS-140HTP, 2.3 μm columns when operated at high flow rate and high pressure.
Figure 2
Figure 4 illustrates that high resolution of a peptide digest from beta-lactoglobulin can be obtained within minutes on a 2.1mm ID × 5cm TSKgel ODS-140HTP, 2.3μm column at a back pressure of about 35MPa (the highest pressure at about 15% acetonitrile in the gradient), i.e. still achievable in traditional HPLC systems. As expected, peak capacity improved when using a longer gradient time.
Figure 3
TSK-GEL ODS-140HTP, 2.3μm reversed phase HPLC columns from Tosoh Bioscience provide high resolution and short analyses times at moderate pressures, enabling high throughput separations. These columns were designed to be used with either UPLC® (up to 9000psi) or in conventional HPLC systems.
Figure 4
For use in high throughput applications, including drug discovery, pharmacokinetics and peptide digest separations, TSK-GEL ODS-140HTP, 2.3μm columns offer excellent resolution.
Tosoh Bioscience LLC
156 Keystone Drive, Montgomeryville, PA 18936
Tel. 215-283-5000 / 800-366-4875
Fax: 215-283-5035
Pick Your Poison: Isolation of Paclitaxel (Octt 2024)
October 4th 2024The diterpenoid, paclitaxel, which was identified as a potent chemotherapy agent for breast and ovarian cancer originates from the Pacific Yew tree. The isolation of paclitaxel from its major impurities is shown with the use of Hamilton’s PRP-1 (5 µm) HPLC column.